ZYME
Zymeworks Inc.
NASDAQ · Healthcare · Biotechnology · CA
$25.54
+2.04%Forward multiples
Based on analyst estimates
- P/E forward
- 66.30x
- P/E 2026E
- 24.49x
- P/E 2027E
- 24.96x
- P/E 2028E
- 57.29x
- P/S forward
- 5.26x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 22.80x
- Price / sales
- 49.36x
- Price / cash flow
- -15.39x
Enterprise value
- Enterprise value
- $1.8B
- EV / sales
- 49.30x
- EV / EBITDA
- -13.05x
- EV / EBIT
- -11.77x
- Market cap
- $1.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026